Peptide T a new treatment for psoriasis? A study of nine patients.
DOI:
https://doi.org/10.2340/0001555571479483Abstract
Nine patients with recalcitrant and long-standing psoriasis were treated over a period of 28 days with 2 mg Peptide T iv, once daily (22-34 micrograms/kg bodyweight). Eight of them showed an improvement of less than 50% by day 28 and one deteriorated. The patients were evaluated for a further 3 months when no topical or systemic treatment was given. Five patients recovered by more than 50%, during the months following termination of the therapy. Two patterns of healing were noted: firstly, a steady clearance beginning immediately with the Peptide T infusions secondly, a clearance pattern preceded by deterioration. No serious side effects were noted.Downloads
Download data is not yet available.
Downloads
Published
1991-01-01
How to Cite
Marcusson, J. A., Talme, T., Wetterberg, L., & Johansson, O. (1991). Peptide T a new treatment for psoriasis? A study of nine patients. Acta Dermato-Venereologica, 71(6), 479–483. https://doi.org/10.2340/0001555571479483
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
